Cancer Immunology

A cancer vaccine is an immunization that either treats existing tumor or averts improvement of a malignancy. Antibodies that regard existing malignancy are known as restorative tumor vaccines. One way to deal with disease immunization is to separate proteins from growth cells and vaccinate patients against those proteins as antigens, in the expectation of empowering the immune system to execute the cancer cells. Another approach is to produce a resistant reaction in situ in the patient utilizing oncolytic infections.

  • Tumor vaccines
  • Oncolytic infections
  • Resistant reactions in situ
  • Proteins as antigens

Related Conference of Cancer Immunology

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Cancer Immunology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in